{"id":458611,"date":"2021-03-16T08:33:16","date_gmt":"2021-03-16T12:33:16","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=458611"},"modified":"2021-03-16T08:33:16","modified_gmt":"2021-03-16T12:33:16","slug":"daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/","title":{"rendered":"Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, March  16, 2021  (GLOBE NEWSWIRE) &#8212; <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=R9aNjdfCk7zACIhnapPxGAWT-E88e1GdWVXVcgSGso4bUCHPrF9w7hgBlnkK-A7K0XpK0TrIHmIoncgMF5cCrw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Daxor Corporation<\/a><\/u> (NYSE: DXR), the global leader in blood volume measurement technology, announces today that President and CEO Michael Feldschuh will present at Maxim Group <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VYQFW6M6VUSmN7fdChtaM5Kx7G0ho3Q_zB-4z6wopDZZZLrsba5Vp9bdWwtq6c12lN9mqD_OEiK_A1Wm6pfTDF2QREcHW_YlG2srLX3U8j6mbGaCgu5LXTFKVbW46I_Lj1Rq0xrPmlAgOQZLFnLf91quJTeTxfeCFM9Gs8yadGtk1zweMJqjYaksvwz_oTpP\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">2021 Emerging Growth Virtual Conference <\/a><\/u>to be held March 17-19, 2021, 9:00 AM &#8211; 5:00 PM EST.<\/p>\n<p align=\"justify\">Mr. Feldschuh will highlight the many recent accomplishments of the Company including accelerating revenue, groundbreaking research and product development, contracts with the US Department of Defense, grant funding through the NIH, and new prospective medical trials for the use of Daxor\u2019s BVA-100\u00ae blood test in the management of critical care, COVID-19, and heart failure with leading institutions.<\/p>\n<p align=\"justify\">Investors can view Mr. Feldschuh\u2019s general corporate presentation once they register for the conference, and an archived replay of the presentation will be available via the conference website. Investors can also request a one-on-one meeting with Mr. Feldschuh following the conclusion of the conference.<\/p>\n<p align=\"justify\">Event: Maxim Group\u2019s Inaugural Emerging Virtual Conference<br \/>Date: March 17th -19th, 9:00 AM &#8211; 5:00 PM EST<br \/>Register <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=n4SQihvBsZ5kT0pT0t8ByNNhJBD6GLT4421XTbM-ZEXnDebkcknKQIDHUzrRQCycP23G1n_j_uc-D5rYS0Y44OcmUhUgF16c6J5B_GVeIQ2sAx3fAeMX_F_FHf85MjTy\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">here<\/a><\/u>.<\/p>\n<p align=\"justify\">Interested investors can contact Bret Shapiro at COREIR either by calling 1-516-222-2560 or emailing <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gk2vU529S1BJPVT6j-53_whjqQBCUxDLPNgqmKIgAEmSsrWYa0FpRhxSV6pTEDJEW0t3a5WTnTvoMIcIQHrqdg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">brets@coreir.com<\/a><\/u>.<\/p>\n<p align=\"justify\">\n        <strong>About Daxor Corporation<\/strong><br \/>\n        <br \/>Daxor Corporation (NYSE: DXR) is the global leader in blood volume measurement technology focused on blood volume testing innovation (organized as an investment company with fully-owned innovative medical instrumentation and biotechnology operations). We developed and market the BVA-100\u00ae (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. The BVA technology enhances hospital performance metrics in a broad range of surgical and medical conditions, including heart failure and critical care, by informing treatment strategies, resulting in significantly improved multiple measures of patient outcomes. Daxor&#8217;s mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor\u2019s vision is optimal blood volume for all. For more information, please visit our website at <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AwDXKvf4Y04K7KZseX9Z126Y51OEYf1IaR5LRRpSr6N5UWZXEjIPE-Q93qmY3TdV5xGn-YAO_fWQ9TzpxSKMmA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Daxor.com<\/a><\/u>.<\/p>\n<p align=\"justify\">\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Bret Shapiro<br \/>Sr. Managing Partner, CORE IR<br \/>516-222-2560<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gk2vU529S1BJPVT6j-53_wEO8kwYVso_3ZXzZTYyX-vOU6tTzyxTLbsglrumm9njjCM5TRMHrDa8f0ojTacBwg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">brets@coreir.com<\/a><\/u><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDUyNyM0MDY1NjMzIzIwODQzNDY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/a0053a69-cdef-4614-8eac-0d92a489b63a\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) &#8212; Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announces today that President and CEO Michael Feldschuh will present at Maxim Group 2021 Emerging Growth Virtual Conference to be held March 17-19, 2021, 9:00 AM &#8211; 5:00 PM EST. Mr. Feldschuh will highlight the many recent accomplishments of the Company including accelerating revenue, groundbreaking research and product development, contracts with the US Department of Defense, grant funding through the NIH, and new prospective medical trials for the use of Daxor\u2019s BVA-100\u00ae blood test in the management of critical care, COVID-19, and heart failure with leading institutions. Investors can view Mr. Feldschuh\u2019s general corporate presentation once they register for the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-458611","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) &#8212; Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announces today that President and CEO Michael Feldschuh will present at Maxim Group 2021 Emerging Growth Virtual Conference to be held March 17-19, 2021, 9:00 AM &#8211; 5:00 PM EST. Mr. Feldschuh will highlight the many recent accomplishments of the Company including accelerating revenue, groundbreaking research and product development, contracts with the US Department of Defense, grant funding through the NIH, and new prospective medical trials for the use of Daxor\u2019s BVA-100\u00ae blood test in the management of critical care, COVID-19, and heart failure with leading institutions. Investors can view Mr. Feldschuh\u2019s general corporate presentation once they register for the &hellip; Continue reading &quot;Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-16T12:33:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDUyNyM0MDY1NjMzIzIwODQzNDY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference\",\"datePublished\":\"2021-03-16T12:33:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\\\/\"},\"wordCount\":347,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDUyNyM0MDY1NjMzIzIwODQzNDY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\\\/\",\"name\":\"Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDUyNyM0MDY1NjMzIzIwODQzNDY=\",\"datePublished\":\"2021-03-16T12:33:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDUyNyM0MDY1NjMzIzIwODQzNDY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDUyNyM0MDY1NjMzIzIwODQzNDY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/","og_locale":"en_US","og_type":"article","og_title":"Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference - Market Newsdesk","og_description":"NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) &#8212; Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announces today that President and CEO Michael Feldschuh will present at Maxim Group 2021 Emerging Growth Virtual Conference to be held March 17-19, 2021, 9:00 AM &#8211; 5:00 PM EST. Mr. Feldschuh will highlight the many recent accomplishments of the Company including accelerating revenue, groundbreaking research and product development, contracts with the US Department of Defense, grant funding through the NIH, and new prospective medical trials for the use of Daxor\u2019s BVA-100\u00ae blood test in the management of critical care, COVID-19, and heart failure with leading institutions. Investors can view Mr. Feldschuh\u2019s general corporate presentation once they register for the &hellip; Continue reading \"Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-16T12:33:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDUyNyM0MDY1NjMzIzIwODQzNDY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference","datePublished":"2021-03-16T12:33:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/"},"wordCount":347,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDUyNyM0MDY1NjMzIzIwODQzNDY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/","name":"Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDUyNyM0MDY1NjMzIzIwODQzNDY=","datePublished":"2021-03-16T12:33:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDUyNyM0MDY1NjMzIzIwODQzNDY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDUyNyM0MDY1NjMzIzIwODQzNDY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-to-participate-in-the-maxim-group-2021-emerging-growth-virtual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/458611","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=458611"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/458611\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=458611"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=458611"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=458611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}